IFNA1 and COVID-19: We have tried to evaluate the available data on repurposing drugs from the beginning of their trials, including the lessons learned from the experience from using various therapeutic molecules to treat the COVID-19 patients like hydroxychloroquine, ritonavir/lopinavir, favipiravir, remdesivir, ivermectin, dexamethasone, camostatmesylate, tocilizumab, mavrilimumab, baricitinib, and interferons (IFN).